Loading
Loading…
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Tender Value
₹2 L
EMD Value
Exempted
Closing Date
20 Mar 2026, 11:00 amClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Levetiracetam Tablet (Q2)
Metoprolol Tablet (Q2) Drugs - Pyridoxine 100 mg Tablets (Q1) MSE Relaxation for Years Of Experience and Turnover Yes | Complete Startup Relaxation for Years Of Experience and Turnover Yes | Complete
9100026
GEM/2026/B/7337933
Two Packet Bid
Levetiracetam Tablet,Metoprolol Tablet,Itraconazole Capsule,Anti TB Drugs - Pyridoxine 100 mg Table
24 Paraganas South, West Bengal
Total value wise evaluation
PRODUCT
2 documents required · 2 mandatory
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| Levetiracetam Tablet (Q2) | - | 90,100 | - |
Exempted
Yes
20 Mar 2026
10 Mar 2026
20 Mar 2026
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9100026.pdf
GEM_BID
technical-specifications-of-pyridoxine-100mg-1_2022-02-07-15-06-01_efd23d74651fc1520384293378d33080.pdf
SPECIFICATION
ATC_866fd620-0d12-4bdd-a1161773119110995_dr.alip.ray.pdf
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
technical-specifications-of-pyridoxine-100mg-1_2022-02-07-15-06-01_efd23d74651fc1520384293378d33080.pdf
GEM_SPEC • 0.95 MB
ATC_866fd620-0d12-4bdd-a1161773119110995_dr.alip.ray.pdf
GEM_OTHER • 0.25 MB
list-of-categories-where-trials-are-allowed_1712126171.pdf
GEM_OTHER • 0.52 MB
gtc.pdf
GEM_OTHER • 0.70 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .